After a thoughtful analysis and in line with the EPTRI Position paper available here yesterday, 07 November 2023, EPTRI submitted its proposal for amendments to the attention of some interested Members of the European Parliament (MEPs). The amendments are related to...
On October 16th EPTRI, after collecting the opinion of several key Paediatric Research Organisation and paediatric interested Stakeholders, provided its feedback on the EU Pharma Legislation by submitting the Position Paper ‘PROPOSED CHANGES TO THE PAEDIATRIC...
The MEP Interest Group 2023 Conference “COUNTDOWN TO EU ELECTIONS: How can policymakers secure the promise of Advanced Therapies for patients over the next 6 months?”, organised by the European Alliance for Transformative Therapies (TRANSFORM) was held last October...
The Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion in favor of the approval of AGAMREE® (vamorolone) for the treatment of Duchenne Muscular Dystrophy (DMD) patients aged 4 years and older. Vamorolone is a novel drug candidate...
On 10 October 2023, the 2023 annual workshop of the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) presented an opportunity for stakeholders to come together and exchange ideas to improve clinical trials for children. The event...
Our first webinar “Investment and commercial opportunities in child health technology” chaired by Paul Dimitri, was held on September 5th. This webinar, organized by our Paediatric Medical Device Research Platform, is part of a one year online educational programme...
Neonatal immune activation by lipopolysaccharide causes inadequate emotional responses to novel situations but no changes in anxiety or cognitive behavior in Wistar rats. Iveta Vojtechova, Tomas Petrasek, Kristyna Maleninska, Hana Brozka, Hana Tejkalova, Jiri Horacek,...
Adriana Ceci, Catherine Tuleu, Donato Bonifazi, Hana Kubova, Irmgard Toni, Marialuisa Lavitrano, Mariangela Lupo, Valeria Pignataro British Journal of Pharmacy DOI: 10.5920/bjpharm.614 https://www.bjpharm.org.uk/article/id/614/
On 20 October 2021, the Decree of the Italian Minister of University and Research adopting the National Research Infrastructure Plan (PNIR) 2021-2027 as an integral part of the National Research Program 2021-2027 (PNR) was published. The European Paediatric...
Dear Colleagues,
I am happy to share with you the October issue of the EPTRI Newsletter which sees the EPTRI participation in several important paediatric research initiatives.